| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $2.3B | $0.5B | $2.1B |
| Cost of Revenue | $1.3B | $0.3B | $1.3B |
| Gross Profit | — | $0.2B | — |
| R&D Expense | $0.0B | $0.0B | $0.1B |
| SG&A Expense | — | $0.5B | $0.5B |
| Operating Income | $0.4B | $0.1B | $0.3B |
| Net Income | $0.4B | $0.3B | $0.3B |
| EPS (Basic) | $6.38 | $1.41 | $4.51 |
| EPS (Diluted) | $6.26 | $1.38 | $4.45 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $3.9B | $2.6B | $2.3B |
| Current Assets | $2.6B | $1.4B | $1.1B |
| Cash & Equivalents | $0.5B | $0.3B | $0.3B |
| Total Liabilities | — | — | — |
| Current Liabilities | $0.5B | $0.5B | $0.5B |
| Stockholders' Equity | $2.1B | $1.6B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | — | — | — |
| Investing Cash Flow | — | — | — |
| Capital Expenditures | — | — | — |
| Financing Cash Flow | $0.8B | $-0.0B | $-0.4B |